Cencora Inc. stock outperforms competitors on strong trading day
Shares of Cencora Inc. COR advanced 1.22% to $264.14 Tuesday, on what proved to be an all-around dismal trading session for ...
Drug Store News3d
Alto, Cencora team up to optimize patient experience for specialty medications
“Alto helps our partners elevate the patient experience, improve medication access and set new standards for convenience, ...
Independent Advisor Alliance Increases Stake in Cencora, Inc. (NYSE:COR)
Independent Advisor Alliance increased its holdings in shares of Cencora, Inc. (NYSE:COR – Free Report) by 64.7% during the ...
Zacks.com on MSN4d
Here is Why Growth Investors Should Buy Cencora (COR) Now
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great ...
3 Market-Beating Stocks to Target This Week
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those ...
Cencora, Inc. (COR): Among Top Insider Sales Last Month
We recently published a list of Top 10 Insider Sales Last Month. In this article, we are going to take a look at where ...
Nasdaq4d
Here is Why Growth Investors Should Buy Cencora (COR) Now
Cencora (COR) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank. Studies have shown that ...
The Print on MSN2d
How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the US
Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...